Abstract
Teprotumumab (teprotumumab-trbw; TEPEZZA (TM) - Horizon Therapeutics) is a monoclonal antibody insulin-like growth factor-I receptor (IGF-IR) antagoni......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
